Procrit can speed tumor growth and hasten death in cancer patients, and in 2002 the FDA advised doctors to stop prescribing it liberally. A WSJ investigation shows one Florida group continues to ...

BRIDGEWATER, N.J., March 7 /PRNewswire/ -- Ortho Biotech Products, L.P. today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the U.S. Food and Drug ...

Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...

FDA is requiring that Erythropoiesis-Stimulating Agents (ESAs) be prescribed and used under a special risk management program. This program is designed to inform healthcare providers and their ...

Dec. 2, 2005 -- The US Food and Drug Administration (FDA), Amgen Inc, and Ortho Biotech Clinical Affairs, LLC, have notified healthcare professionals via letter regarding revisions to the safety ...

The Procrit kickback case is back. A U.S. federal appeals court has reinstated a whistleblower suit against Johnson & Johnson's drug subsidiary that accused the company of defrauding Medicare.

The US Food and Drug Administration has approved Pfizer’s Retacrit, a biosimilar of Amgen's Epogen and Johnson & Johnson's Procrit. The US Food and Drug Administration has approved Pfizer’s Retacrit, ...

Gaithersburg, MD (September 11, 2007) – As the Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) and Drug Safety and Risk Management Advisory Committee ...

Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...